-
Real-World Evidence From Community Oncology: Assessing Secular Trends in Ovarian Cancer Diagnoses From 2014 to 2024
Sep 9, 2025, 16:22 PM -
Systems Simulation Methods for the Economic Evaluation of Non-Medicines and Nonsurgical Interventions: A Systematic Literature Review of Quality and Methods for Reproducing Complexity in Health and Health Behaviors
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Healthcare Resource Utilization Among Patients With Immune Thrombocytopenia: A Real-World Survey
Sep 9, 2025, 16:22 PM -
Patient and Societal Preferences for On-Demand Treatment in Hereditary Angioedema: Estimation of Utility Using a Discrete Choice Experiment
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization in Patients With Hidradenitis Suppurativa Using Adelphi Real-World Data From EU5 and US
Sep 9, 2025, 16:22 PM -
Is Protocolized Stopping Lifelong Therapy With Eculizumab With Disease Monitoring and Retreatment for Eligible Atypical Hemolytic Uremic Syndrome (aHUS) Patients Cost-Effective? An Economic Evaluation of the SETS aHUS Trial
Sep 9, 2025, 16:22 PM -
Economic Evaluation Of Cefiderocol for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii in Italy Using Real-World Evidence
Sep 9, 2025, 16:22 PM -
From French Early Access to Regular Reimbursement: How Do Prices Shift Post-HTA?
Sep 9, 2025, 16:22 PM -
Monitoring the Burden of Lung Cancer in Germany: Trends in Incidence and Survival Using ZfKD Registry Data 2020-2023
Sep 9, 2025, 16:22 PM -
Evaluating Cost Benefits of Subcutaneous vs. Intravenous Trastuzumab/Pertuzumab in HER2-Positive Early Breast Cancer Patients: From Qatari Healthcare Perspective
Sep 9, 2025, 16:22 PM -
Accounting for Bereavement in NICE Pediatric Health Technology Appraisals: A Review of the Inclusion of Caregiver Health Utilities After the Death of a Child
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Early Scientific Advice Mechanisms: EU JSC vs. National HTA Bodies (HAS, G-BA, NICE)
Sep 9, 2025, 16:22 PM -
Potential Benefits of Universal Influenza Vaccination on Health Outcomes and Costs in Mexico
Sep 9, 2025, 16:22 PM -
Urinary Dysfunction Management in Multiple Sclerosis: A Nationwide Real-Life Analysis From the French SNDS Database
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Economic Burden Among Adults With Alopecia Areata in the United Arab Emirates
Sep 9, 2025, 16:22 PM -
Survival Model Uncertainty in Economic Modeling: Evaluating Bootstrap and Cholesky Decomposition Methods
Sep 9, 2025, 16:22 PM -
Leveraging a Multicountry Real-World Data Observatory to Monitor Respiratory Tract Infections and Evaluate Public Health Interventions in Europe
Sep 9, 2025, 16:22 PM -
Socioeconomic Burden Among Children and Adults With Achondroplasia in Europe and Latin America
Sep 9, 2025, 16:22 PM -
Excel Front-End, R Back-End: A Gateway to Faster Individual Patient Simulations and Probabilistic Sensitivity Analyses in Cost-Effectiveness Models for HTA
Sep 9, 2025, 16:22 PM -
Therapeutic Benefit of Radiotherapy in Uterine Serous Carcinoma (USC): A Real-World Study
Sep 9, 2025, 16:22 PM
